FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC FDA to weigh easing limits on unproven peptides How different peptide therapies may affect your body Prenuvo blog Most people hear not FDA approved and immediately think unsafe or ineffective but the reality is a lot more about economics than science. If something can't be patented, there's little incentive to FDA moves toward easing restrictions on certain peptides BioPharma Dive